Compare AYTU & UGRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AYTU | UGRO |
|---|---|---|
| Founded | N/A | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Industrial Specialties |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.4M | 3.0M |
| IPO Year | N/A | N/A |
| Metric | AYTU | UGRO |
|---|---|---|
| Price | $2.42 | $0.34 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $9.33 | $3.00 |
| AVG Volume (30 Days) | 52.7K | ★ 3.0M |
| Earning Date | 11-13-2025 | 03-27-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $63,696,000.00 | $59,985,138.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $47.30 | $28.40 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.95 | $0.21 |
| 52 Week High | $2.82 | $1.26 |
| Indicator | AYTU | UGRO |
|---|---|---|
| Relative Strength Index (RSI) | 67.87 | 62.18 |
| Support Level | $2.05 | $0.23 |
| Resistance Level | $2.39 | $0.41 |
| Average True Range (ATR) | 0.10 | 0.04 |
| MACD | 0.03 | 0.02 |
| Stochastic Oscillator | 87.39 | 62.04 |
Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline, including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates one business segment consisting of various prescription pharmaceutical products sold through third parties.
Urban-gro Inc is an integrated professional services and construction design-build firm. Its business focuses predominantly on providing fee-based knowledge-based services as well as the value-added reselling of equipment. The company offers value-added architectural, engineering, systems procurement and integration, and construction design-build solutions to customers operating in the controlled environment agriculture (CEA) and industrial and other commercial (Commercial) sectors. It derives revenue predominately from the sale of equipment systems, services, construction design-build, and other various immaterial contracts with customers.